论文部分内容阅读
目的分析紫杉醇+顺铂方案联合同步放疗治疗中晚期食管癌的临床效果。方法盲选本院收治的74例中晚期食管癌患者,分别采用单纯放疗以及紫杉醇+顺铂方案联合同步放疗的治疗,比较两组患者的治疗效果及1、2年生存率。结果乙组患者治疗有效率及1、2年生存率明显高于甲组,比较差异有统计学意义(P<0.05)。结论采用紫杉醇+顺铂方案联合同步放疗治疗中晚期食管癌治疗,可有效提高患者生命质量,疗效显著,值得应用推广。
Objective To analyze the clinical effect of paclitaxel + cisplatin combined with concurrent radiotherapy in the treatment of advanced esophageal cancer. Methods A total of 74 patients with advanced esophageal cancer who were treated in our hospital were blindly treated with radiotherapy alone and paclitaxel + cisplatin combined with concurrent radiotherapy. The therapeutic effect and the 1 and 2 year survival rates were compared between the two groups. Results The effective rate of treatment in group B and the 1-year and 2-year survival rates were significantly higher than those in group A, with significant difference (P <0.05). Conclusion Paclitaxel + cisplatin combined with concurrent radiotherapy for the treatment of advanced esophageal cancer can effectively improve the quality of life of patients with significant effect, it is worth to promote the application.